MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stake in Xylem Inc. $XYL

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Xylem Inc. (NYSE:XYL) by 9.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,750 shares of the industrial products company’s stock after purchasing an additional 4,021 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Xylem were worth $5,346,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Xylem by 1.3% during the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after purchasing an additional 362,127 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Xylem by 7.9% during the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company’s stock worth $506,985,000 after purchasing an additional 320,500 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Xylem by 8.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company’s stock worth $435,119,000 after purchasing an additional 301,070 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after purchasing an additional 3,239,203 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of Xylem by 2.9% during the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after purchasing an additional 94,560 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

NYSE:XYL opened at $141.75 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The firm has a market capitalization of $34.50 billion, a price-to-earnings ratio of 36.82, a PEG ratio of 2.38 and a beta of 1.09. The company’s 50-day moving average is $138.01 and its two-hundred day moving average is $127.52. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33.

Xylem (NYSE:XYL) last posted its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem’s revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is presently 41.56%.

Analysts Set New Price Targets

XYL has been the subject of a number of research reports. Cowen reissued a “hold” rating on shares of Xylem in a research note on Tuesday, August 26th. Citigroup reiterated a “buy” rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. UBS Group increased their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a “buy” rating in a report on Tuesday, August 5th. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Finally, Raymond James Financial upgraded shares of Xylem to a “hold” rating in a report on Thursday, May 15th. Six research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and an average price target of $152.29.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.27% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.